Coronavirus: Vaccination

Department of Health and Social Care written question – answered on 23 May 2023.

Alert me about debates like this

Photo of Esther McVey Esther McVey Conservative, Tatton

To ask the Secretary of State for Health and Social Care, if he will make an assessment of the implications for his policies on covid-19 vaccinations of the study by Fraiman, J., et al., entitled Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults published in the journal Vaccine on 22 September 2022.

Photo of Maria Caulfield Maria Caulfield The Parliamentary Under-Secretary for Health and Social Care, Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)

Each COVID-19 vaccine candidate is assessed by teams of scientists and clinicians and only authorised once it has met robust standards of safety, quality, and effectiveness set by the Medicines and Healthcare products Regulatory Agency (MHRA).

The MHRA and the UK Health Security Agency continuously monitor the safety of all COVID-19 vaccines, including through reviewing all suspected Adverse Drug Reaction reports, and other data from the United Kingdom and internationally. Since the start of the pandemic, the National Institute for Health and Care Research has also allocated more than £110 million in funding for COVID-19 vaccine research, including consideration of vaccine safety.

Does this answer the above question?

Yes1 person thinks so

No1 person thinks not

Would you like to ask a question like this yourself? Use our Freedom of Information site.